首页>
外国专利>
CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR THYMIC STROMAL LYMPHOPOIETIN RECEPTOR, AND METHODS FOR USE THEREOF
CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR THYMIC STROMAL LYMPHOPOIETIN RECEPTOR, AND METHODS FOR USE THEREOF
展开▼
机译:胸腺基质淋巴细胞生成素受体的嵌合抗原受体及其使用方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine; pharmaceuticals.;SUBSTANCE: present invention relates to immunology. Disclosed is a chimeric antigenic receptor (CAR) containing an antigen-binding domain specific for thymic stromal lymphopoietin receptor (TSLPR), a transmembrane domain and an intracellular domain of T-cell signaling. Also disclosed is a CAR coding nucleic acid, a vector, a host cell, a cell population, a pharmaceutical composition, a method for detecting cancer, methods of treating or preventing cancer and proliferative disorder and a method for determining whether a subject with a proliferative disease is a candidate for treating the aforesaid CAR.;EFFECT: present invention can find further application in adoptive therapy of various diseases associated with a mutation in the IKZF gene and characterized by high expression of TSLPR, such as acute lymphoblastic leukemia (ALL).;30 cl, 26 dwg, 3 tbl, 2 ex
展开▼
机译:领域:医学;药物。物质:本发明涉及免疫学。公开了一种嵌合抗原受体(CAR),其包含对胸腺基质淋巴细胞生成素受体(TSLPR)具有特异性的抗原结合结构域,跨膜结构域和T细胞信号传导的细胞内结构域。还公开了CAR编码核酸,载体,宿主细胞,细胞群体,药物组合物,用于检测癌症的方法,用于治疗或预防癌症和增生性疾病的方法以及用于确定受试者是否患有增生性疾病的方法。该疾病是用于治疗上述CAR的候选者。效果:本发明可以发现在与IKZF基因突变相关并以TSLPR的高表达为特征的多种疾病的继发治疗中进一步应用,例如急性淋巴细胞白血病(ALL)。 ; 30 cl,26 dwg,3 tbl,2 ex
展开▼